Skip to content

GujjuTicks brief

Sun Pharma's profit falls on Organon deal charge; specialty drug sales remain strong

India's Sun Pharmaceutical Industries reported a drop in second-quarter profit on Friday, as ​a one-time charge largely tied to its planned ... This GujjuTicks brief summarizes the headline for local readers; read the full story on the publisher site.

This is a short GujjuTicks summary for discovery. Full reporting and quotes belong to the original publisher.

Read full story More in India health news Today’s edition